88 results
Page 3 of 5
8-K
EX-99.1
7r03y0j
2 May 19
Agios Reports Business Highlights and First Quarter 2019 Financial Results
7:24am
8-K
EX-99.1
4aqe q2ts4i9ioc
14 Feb 19
Agios Reports Fourth Quarter and Full Year 2018 Financial Results
7:16am
8-K
4c79y4
3 Dec 18
Other Events
4:03pm
8-K
EX-99.1
f6d3dbcq 33szyt
3 Dec 18
Other Events
4:03pm
8-K
EX-99.2
cewu1ot1
3 Dec 18
Other Events
4:03pm
8-K
ggnf ou44gk
16 Nov 18
Agios Presents Updated Data from Phase 1 Dose-Escalation Study ofAG-881 in Patients with IDH Mutant Positive Advanced Glioma
4:01pm
8-K
EX-99.1
szr3sg 3en280mcxd
16 Nov 18
Agios Presents Updated Data from Phase 1 Dose-Escalation Study ofAG-881 in Patients with IDH Mutant Positive Advanced Glioma
4:01pm
8-K
EX-99.1
ladiv m7nm
1 Nov 18
Agios Reports Third Quarter 2018 Financial Results
7:45am
8-K
EX-99.1
i6hnwd
2 Aug 18
Agios Reports Second Quarter 2018 Financial Results
7:28am
8-K
EX-99.1
b6heou2d
20 Jul 18
FDA Grants Approval of TIBSOVO®, the First Oral, Targeted Therapy for Adult Patients
11:21am
8-K
EX-99.2
8j83rmieg oe8dhrug3c
4 May 18
Results of Operations and Financial Condition
7:07am
8-K
EX-99.1
nuvp1 fwy
4 May 18
Results of Operations and Financial Condition
7:07am